ArticleJournal of biomedical science2025
Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4.
Zhangyuan Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it